Tag
Oncology
2 articles
Sakar Healthcare Q1 PAT Surges 120% YoY
Sakar Healthcare reported Q1FY27 consolidated revenue of ₹7,297 lakhs, up 38% YoY, with PAT surging 120% to ₹1,028 lakhs.
The oncology business drove growth with 65 product contracts, 16 marketing aut
Beta Drugs Q1 FY27 Revenue Rises 47% YoY
Beta Drugs Ltd. presents its July 2026 investor overview, highlighting a diversified specialty pharma business across oncology, dermatology, and IVF.
Q1 FY27 consolidated revenue was INR 1,255 Mn with